ProfileGDS4718 / 233244_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 63% 58% 66% 58% 63% 67% 62% 62% 59% 59% 60% 62% 65% 65% 55% 57% 67% 66% 77% 66% 59% 58% 57% 60% 64% 59% 67% 58% 64% 69% 63% 59% 57% 64% 62% 69% 65% 61% 55% 57% 67% 61% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9853258
GSM549102patient 115, normal, homogenized [OPG study]6.3592663
GSM549104patient 119, normal, homogenized [OPG study]5.9734458
GSM549108patient 138, normal, homogenized [OPG study]6.5212266
GSM549119patient 077, normal, homogenized [OPG study]6.0043158
GSM549133patient 032, cancer, homogenized [OPG study]6.329563
GSM549139patient 042, cancer, homogenized [OPG study]6.6425967
GSM549099patient 107, normal, homogenized [OPG study]6.2667962
GSM549109patient 139, normal, homogenized [OPG study]6.275162
GSM549110patient 046, normal, homogenized [OPG study]6.0365359
GSM549114patient 063, normal, homogenized [OPG study]6.0150759
GSM549122patient 082, normal, homogenized [OPG study]6.1410960
GSM549134patient 033, cancer, homogenized [OPG study]6.2640862
GSM549136patient 036, cancer, homogenized [OPG study]6.4616365
GSM549140patient 044, cancer, homogenized [OPG study]6.4673365
GSM549111patient 047, normal, homogenized [OPG study]5.7822755
GSM549113patient 057, normal, homogenized [OPG study]5.9232157
GSM549132patient 031, cancer, homogenized [OPG study]6.6083567
GSM549137patient 038, cancer, homogenized [OPG study]6.5979166
GSM549142patient 047, cancer, homogenized [OPG study]7.3417977
GSM549100patient 110, normal, homogenized [OPG study]6.543666
GSM549107patient 135, normal, homogenized [OPG study]6.0341259
GSM549115patient 068, normal, homogenized [OPG study]5.9300258
GSM549116patient 072, normal, homogenized [OPG study]5.9313557
GSM549120patient 078, normal, homogenized [OPG study]6.1058760
GSM549131patient 030, cancer, homogenized [OPG study]6.3752564
GSM549118patient 074, normal, homogenized [OPG study]6.0527859
GSM549129patient 027, cancer, homogenized [OPG study]6.671567
GSM549123patient 088, normal, homogenized [OPG study]5.9794558
GSM549124patient 006, cancer, homogenized [OPG study]6.4299864
GSM549126patient 015, cancer, homogenized [OPG study]6.7558469
GSM549128patient 025, cancer, homogenized [OPG study]6.3527363
GSM549103patient 117, normal, homogenized [OPG study]6.044859
GSM549117patient 073, normal, homogenized [OPG study]5.8669857
GSM549138patient 041, cancer, homogenized [OPG study]6.4498764
GSM549141patient 045, cancer, homogenized [OPG study]6.2848962
GSM549130patient 028, cancer, homogenized [OPG study]6.7521469
GSM549101patient 111, normal, homogenized [OPG study]6.4851565
GSM549105patient 128, normal, homogenized [OPG study]6.2125261
GSM549106patient 134, normal, homogenized [OPG study]5.7725255
GSM549112patient 048, normal, homogenized [OPG study]5.9178657
GSM549125patient 011, cancer, homogenized [OPG study]6.657467
GSM549127patient 024, cancer, homogenized [OPG study]6.2654961
GSM549135patient 035, cancer, homogenized [OPG study]5.9913858